# Citizens & Northern Corp: financial statements, quarterly

CZNC · Nasdaq · CIK 810958 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cznc.md) · [Financials](/companies/cznc/financials.md) · [Filings](/companies/cznc/filings.md) · [Insiders](/companies/cznc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cznc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [9.5](/filings/0001558370-23-017696.md) | [10.6 d](/filings/0001558370-24-002879.md) | [11.3](/filings/0001558370-24-007016.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.8](/filings/0001558370-24-014605.md) | [1.7 d](/filings/0001104659-26-024613.md) | [1.2](/filings/0001558370-25-007103.md) | [1.4](/filings/0001558370-25-010889.md) | [1.4](/filings/0001104659-25-108331.md) | [1.9 d](/filings/0001104659-26-024613.md) | [1.4](/filings/0001104659-26-057705.md) | [1.4](/filings/0001104659-26-092539.md) | [1.5](/filings/0001104659-25-108331.md) | [0.9 d](/filings/0001104659-26-024613.md) | [0.1](/filings/0001104659-26-057705.md) | [3.4](/filings/0001104659-26-092539.md) |
| Net income | $m | [7.6](/filings/0001558370-24-014605.md) | [4.3 d](/filings/0001104659-26-024613.md) | [5.3](/filings/0001558370-25-007103.md) | [6.1](/filings/0001558370-25-010889.md) | [6.4](/filings/0001104659-25-108331.md) | [8.2 d](/filings/0001104659-26-024613.md) | [6.3](/filings/0001104659-26-057705.md) | [6.1](/filings/0001104659-26-092539.md) | [6.6](/filings/0001104659-25-108331.md) | [4.5 d](/filings/0001104659-26-024613.md) | [0.3](/filings/0001104659-26-057705.md) | [14.1](/filings/0001104659-26-092539.md) |
| Diluted EPS | $ per share | [0.50](/filings/0001558370-24-014605.md) | not reported | [0.35](/filings/0001558370-25-007103.md) | [0.40](/filings/0001558370-25-010889.md) | [0.41](/filings/0001104659-25-108331.md) | not reported | [0.41](/filings/0001104659-26-057705.md) | [0.40](/filings/0001558370-25-010889.md) | [0.42](/filings/0001104659-25-108331.md) | not reported | [0.02](/filings/0001104659-26-057705.md) | not reported |
| Basic EPS | $ per share | [0.50](/filings/0001558370-24-014605.md) | not reported | [0.35](/filings/0001558370-25-007103.md) | [0.40](/filings/0001558370-25-010889.md) | [0.41](/filings/0001104659-25-108331.md) | not reported | [0.41](/filings/0001104659-26-057705.md) | [0.40](/filings/0001104659-26-092539.md) | [0.42](/filings/0001104659-25-108331.md) | not reported | [0.02](/filings/0001104659-26-057705.md) | [0.79](/filings/0001104659-26-092539.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.7](/filings/0001558370-23-017696.md) | [56.9](/filings/0001558370-25-002408.md) | [46.4](/filings/0001558370-24-007016.md) | [100](/filings/0001558370-24-011247.md) | [184](/filings/0001558370-24-014605.md) | [126](/filings/0001104659-26-024613.md) | [115](/filings/0001558370-25-007103.md) | [99.6](/filings/0001558370-25-010889.md) | [123](/filings/0001104659-25-108331.md) | [46.1](/filings/0001104659-26-092539.md) | [54.8](/filings/0001104659-26-057705.md) | [82.5](/filings/0001104659-26-092539.md) |
| Total assets | $m | [2,484](/filings/0001558370-23-017696.md) | [2,516](/filings/0001558370-25-002408.md) | [2,522](/filings/0001558370-24-007016.md) | [2,593](/filings/0001558370-24-011247.md) | [2,671](/filings/0001558370-24-014605.md) | [2,611](/filings/0001104659-26-024613.md) | [2,609](/filings/0001558370-25-007103.md) | [2,611](/filings/0001558370-25-010889.md) | [2,664](/filings/0001104659-25-108331.md) | [3,132](/filings/0001104659-26-092539.md) | [3,164](/filings/0001104659-26-057705.md) | [3,152](/filings/0001104659-26-092539.md) |
| Total liabilities | $m | [2,244](/filings/0001558370-23-017696.md) | [2,253](/filings/0001558370-25-002408.md) | [2,260](/filings/0001558370-24-007016.md) | [2,330](/filings/0001558370-24-011247.md) | [2,394](/filings/0001558370-24-014605.md) | [2,335](/filings/0001104659-26-024613.md) | [2,327](/filings/0001558370-25-007103.md) | [2,325](/filings/0001558370-25-010889.md) | [2,370](/filings/0001104659-25-108331.md) | [2,791](/filings/0001104659-26-092539.md) | [2,829](/filings/0001104659-26-057705.md) | [2,806](/filings/0001104659-26-092539.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [23.3](/filings/0001558370-23-017696.md) | [33.9](/filings/0001558370-25-002408.md) | [48.8](/filings/0001558370-24-007016.md) | [16.9](/filings/0001558370-24-011247.md) | [11.4](/filings/0001558370-24-014605.md) | [2.5](/filings/0001104659-26-024613.md) | [0.6](/filings/0001558370-25-007103.md) | [0.5](/filings/0001558370-25-010889.md) | [1.5](/filings/0001104659-25-108331.md) | [28.6](/filings/0001104659-26-092539.md) | [13.6](/filings/0001104659-26-057705.md) | [14.6](/filings/0001104659-26-092539.md) |
| Shareholders' equity | $m | [240](/filings/0001558370-24-014605.md) | [262](/filings/0001104659-26-024613.md) | [262](/filings/0001558370-25-010889.md) | [263](/filings/0001104659-25-108331.md) | [277](/filings/0001104659-25-108331.md) | [275](/filings/0001104659-26-092539.md) | [282](/filings/0001104659-26-092539.md) | [286](/filings/0001104659-26-092539.md) | [294](/filings/0001104659-25-108331.md) | [342](/filings/0001104659-26-092539.md) | [336](/filings/0001104659-26-092539.md) | [346](/filings/0001104659-26-092539.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.5 d](/filings/0001558370-24-014605.md) | [7.7 d](/filings/0001104659-26-024613.md) | [5.7](/filings/0001558370-25-007103.md) | [8.6 d](/filings/0001558370-25-010889.md) | [6.6 d](/filings/0001104659-25-108331.md) | [12.1 d](/filings/0001104659-26-024613.md) | [1.6](/filings/0001104659-26-057705.md) | [8.5 d](/filings/0001104659-26-092539.md) | [11.3 d](/filings/0001104659-25-108331.md) | [10.6 d](/filings/0001104659-26-024613.md) | [8.7](/filings/0001104659-26-057705.md) | [15.4 d](/filings/0001104659-26-092539.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001558370-24-014605.md) | [0.9 d](/filings/0001104659-26-024613.md) | [0.7](/filings/0001558370-25-007103.md) | [0.7 d](/filings/0001558370-25-010889.md) | [0.2 d](/filings/0001104659-25-108331.md) | [0.4 d](/filings/0001104659-26-024613.md) | [0.5](/filings/0001104659-26-057705.md) | [0.5 d](/filings/0001104659-26-092539.md) | [0.4 d](/filings/0001104659-25-108331.md) | [0.5 d](/filings/0001104659-26-024613.md) | [0.2](/filings/0001104659-26-057705.md) | [0.2 d](/filings/0001104659-26-092539.md) |
| Dividends paid | $m | [3.9 d](/filings/0001558370-24-014605.md) | [3.9 d](/filings/0001104659-26-024613.md) | [3.9](/filings/0001558370-25-007103.md) | [3.9 d](/filings/0001558370-25-010889.md) | [3.9 d](/filings/0001104659-25-108331.md) | [3.9 d](/filings/0001104659-26-024613.md) | [3.9](/filings/0001104659-26-057705.md) | [3.9 d](/filings/0001104659-26-092539.md) | [3.9 d](/filings/0001104659-25-108331.md) | [4.5 d](/filings/0001104659-26-024613.md) | [4.6](/filings/0001104659-26-057705.md) | [4.6 d](/filings/0001104659-26-092539.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.4](/filings/0001558370-23-013798.md) | [15.4](/filings/0001558370-23-017696.md) | [15.4](/filings/0001558370-24-007016.md) | [15.2](/filings/0001558370-24-011247.md) | [15.2](/filings/0001558370-24-014605.md) | [15.2](/filings/0001558370-25-007103.md) | [15.3](/filings/0001558370-25-010889.md) | [15.3](/filings/0001104659-25-108331.md) | [15.3](/filings/0001104659-26-057705.md) | [15.4](/filings/0001558370-25-010889.md) | [15.4](/filings/0001104659-25-108331.md) | [17.7](/filings/0001104659-26-057705.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,934,867 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092539.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.